valsartan/hydrochlorthiazid actavis 160 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 160 mg / 25 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 25 mg
valsartan/hydrochlorthiazid actavis 320 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 320 mg / 25 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 25 mg
glycopyrronium bromide martindale 200 mikrog/ ml
ethypharm (2) - glykopyrroniumbromid - injeksjonsvæske, oppløsning - 200 mikrog/ ml
daurismo
pfizer europe ma eeig - glasdegib maleate - leukemi, myeloid, akutt - antineoplastiske midler - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.
micardisplus 80 mg / 25 mg
2care4 aps - telmisartan / hydroklortiazid - tablett - 80 mg / 25 mg
cozaar comp 100 mg / 12.5 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 12.5 mg
olmetec comp 20 mg / 12.5 mg
2care4 aps - olmesartanmedoksomil / hydroklortiazid - tablett, filmdrasjert - 20 mg / 12.5 mg
cozaar comp 50 mg / 12.5 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg